US Patent Issued to GENMAB on Oct. 7 for "Bispecific antibodies against CD3 and CD20" (American, Dutch, Danish Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,154, issued on Oct. 7, was assigned to GENMAB A/S (Valby, Denmark).

"Bispecific antibodies against CD3 and CD20" was invented by Tahamtan Ahmadi (Rydal, Pa.), Manish Gupta (Skillman, N.J.), Tommy Li (Edison, N.J.), Roberto Oliveri (Copenhagen, Denmark), Dena Demarco (Chatham, N.J.), Ida Hiemstra (Utrecht, Netherlands), Christopher Chiu (Warren, N.J.), Brian Elliott (Hoboken, N.J.) and Ada Azaryan (North Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to bispecific antibodies (bsAbs) and the use of such antibodies in the treatment of disease in subjects. Moreover, advantageous treatment regimens are provided ...